Formulation and Specifications: Tablets: 5 mgIndications: For the treatment of disease-related splenomegaly or disease-related symptoms in adult patients with intermediate-risk or high-risk primary myelofibrosis (also known as chronic idiopathic myelofibrosis),…
Formulation and Specifications: Injection: 100 mg (5 ml)/vial, 400 mg (20 ml)/vialIndications: Monotherapy in adult patients with relapsed and refractory multiple myeloma who have received prior therapy including proteasome inhibitors…
Formulation and Specifications: Capsules: 2.3 mg, 3 mg, 4 mgIndications: In combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least…
Formulation and specifications: (1) Tablets: 25mg; (2) Capsules: 25mgIndications: Neoplastic leprosy.Key points for rational drug use:1. Thalidomide can cause heart rate slowdown and third degree atrioventricular block in severe cases.2.…
Formulation and Specifications: Capsules: 1 mg, 4 mgIndications: Relapsed refractory multiple myeloma: Pomalidomide in combination with dexamethasone for adult multiple myeloma patients who have received at least two prior therapies…
Formulation and Specifications: Capsules: 10mg, 25mgIndications: Primary and relapsed refractory multiple myeloma.Key points for rational drug use:1. The drug has myelosuppressive effect, and the patient’s blood routine needs to be…
Formulation and Specifications: Capsules: 80mgIndications:1. Adult patients with condylomatous lymphoma (MCL) who have received at least one prior therapy.2. Adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who…
Formulation and specifications: Injection: 100mg (10ml)/bottleIndications: Treatment of relapsed or refractory classic Hodgkin’s lymphoma after at least second-line systemic chemotherapy.Key points for rational drug use:1. Baseline evaluation should be done…
Formulation and specifications: Powder injection: 200mg/vialIndications: This product is indicated for the treatment of patients with relapsed or refractory classic Hodgkin’s lymphoma who have undergone at least second-line systemic chemotherapy.Key…
Formulation and specification: Injection: 100mg (10ml)/bottleIndications: This product is indicated for the treatment of relapsed or refractory classic Hodgkin’s lymphoma that has undergone at least second-line systemic chemotherapy.Key points for…